Skip to Main Content

Paper Details

A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result.
Pharmaceuticals (Basel)
2
2023
Author NameAffiliation
Yoichi SakuradaUniversity of Yamanashi
  • 1 - 1

Datasets

Release 1.2